Role of B Cells in Breaking and Maintaining Tolerance to Clotting Factor VIII in Congenital and Acquired Hemophilia A

Immune responses directed against clotting factor FVIII (FVIII) seriously complicate treatments for patients with hemophilia A. This response can manifest in congenital hemophilia A patients who generate inhibitor antibodies that bind and inactivate “transplanted” replacement FVIII, as well as in ac...

Full description

Bibliographic Details
Main Authors: Amanda M. Actor, Claire K. Holley, Keri Csencsits-Smith
Format: Article
Language:English
Published: MDPI AG 2014-04-01
Series:Antibodies
Subjects:
Online Access:http://www.mdpi.com/2073-4468/3/2/192